Long-Term Metformin Use Linked to Fewer ER+ Breast Cancers Long-Term Metformin Use Linked to Fewer ER+ Breast Cancers
Observational data from over 40,000 women with type 2 diabetes documents fewer estrogen receptor-positive breast cancers in those treated with metformin long-term; editorialists question conclusions, however.Medscape Medical News
Source: Medscape Radiology Headlines - Category: Radiology Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Hematology | Metformin | Radiology | Women